Canada markets closed

Werewolf Therapeutics, Inc. (HOWL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.02-0.22 (-3.53%)
At close: 04:00PM EDT
6.02 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 270.49M
Enterprise Value 188.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)11.15
Price/Book (mrq)2.43
Enterprise Value/Revenue 9.43
Enterprise Value/EBITDA -5.79

Trading Information

Stock Price History

Beta (5Y Monthly) 0.71
52-Week Change 3138.17%
S&P500 52-Week Change 323.10%
52 Week High 38.19
52 Week Low 31.57
50-Day Moving Average 36.26
200-Day Moving Average 33.95

Share Statistics

Avg Vol (3 month) 3198.76k
Avg Vol (10 day) 3179.69k
Shares Outstanding 543.35M
Implied Shares Outstanding 643.35M
Float 820.84M
% Held by Insiders 16.28%
% Held by Institutions 164.35%
Shares Short (Apr 15, 2024) 4410.05k
Short Ratio (Apr 15, 2024) 42.45
Short % of Float (Apr 15, 2024) 41.62%
Short % of Shares Outstanding (Apr 15, 2024) 40.95%
Shares Short (prior month Mar 15, 2024) 4431.97k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -187.37%
Operating Margin (ttm)-863.56%

Management Effectiveness

Return on Assets (ttm)-15.11%
Return on Equity (ttm)-31.98%

Income Statement

Revenue (ttm)19.94M
Revenue Per Share (ttm)0.56
Quarterly Revenue Growth (yoy)-79.40%
Gross Profit (ttm)N/A
EBITDA -38.74M
Net Income Avi to Common (ttm)-37.37M
Diluted EPS (ttm)-1.05
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)134.34M
Total Cash Per Share (mrq)3.14
Total Debt (mrq)51.92M
Total Debt/Equity (mrq)46.62%
Current Ratio (mrq)7.14
Book Value Per Share (mrq)2.85

Cash Flow Statement

Operating Cash Flow (ttm)-32.61M
Levered Free Cash Flow (ttm)-22.16M